End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.45 CNY | +0.12% | +1.88% | -24.26% |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-24.26% | 374M | - | ||
-1.44% | 12.58B | B+ | ||
+0.13% | 8.51B | B- | ||
-0.71% | 5.29B | B | ||
+20.18% | 5.16B | C | ||
-0.74% | 4.55B | C | ||
-54.68% | 3.04B | D+ | ||
+24.56% | 3B | - | - | |
+25.13% | 2.17B | C | ||
-1.86% | 1.92B | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688338 Stock
- Ratings Beijing Succeeder Technology Inc.